Position paperSurvivorship after childhood cancer: PanCare: A European Network to promote optimal long-term care
Introduction
Survival after childhood cancer has improved substantially over recent decades. Although cancer in childhood is rare increasingly effective treatments have led to a growing number of long term survivors. This improvement in survival means that one in 1000 individuals in the general population of developed countries is a survivor of childhood cancer [1]. Research has shown that a significant proportion will suffer adverse health outcomes including premature mortality compared with the general population. While chronic health conditions are common among childhood cancer survivors, each specific type of late effect is very rare. Over the last two decades there have been many studies addressing the risks of specific late effects in relation to aspects of previous anti-cancer treatment but they have been hampered by the ability to recruit adequate numbers of survivors. It is estimated that there are between 300,000 and 500,000 childhood cancer survivors in Europe [2]. Such good survival prospects raise important questions relating to late effects of treatment for cancer, particularly when addressing complex multimodality treatments, and taking into account the interaction between aspects of treatment and genotype. By forming a Network across Europe we may be able to effectively answer many of the questions and from the answers improve the holistic care of all survivors.
Childhood cancer survivors deserve an effective structured long-term follow-up system to maximise their quality of life. For many years national groups have been working on special guidelines and recommendations in long-term follow-up; strategies for implementation have been developed, first nationally and then trans-nationally, across Europe [3], [4], [5], [6], [7], [8]. This formed the basis for the networking and collaboration leading to the formation of PanCare in Europe. Since the first meeting in Lund, the goal of the PanCare Network has been to implement these strategies to ensure that every European survivor of childhood and adolescent cancer receives optimal long‐term care. This paper will outline the PanCare Network, our mission statement and the first step towards achieving our ambitions.
Section snippets
Aims and organisational structure
In March 2008 PanCare – the Pan-European Network for Care of Survivors after Childhood and Adolescent Cancer – was founded in Lund, Sweden, at a meeting attended by 26 representatives from 13 European countries (www.pancare.eu). PanCare’s name and mission statement were agreed at the meeting and have remained as follows:
PanCare is a multidisciplinary pan‐European Network of professionals, survivors and their families that aims to reduce the frequency, severity and impact of late side‐effects of
EU funded projects following PanCare networking and surveys
At the conclusion of these surveys it had become clear that European centres, if collaborating, would have the capacity to carry out extensive, broad-based, comprehensive and detailed studies of risks to health in long-term survivors of childhood and adolescent cancer. Allied to this conclusion, it was evident that the current fragmentation and lack of networking between countries and clinics across Europe was hindering the development and implementation of long-term follow-up guidelines. In
Partnering with parent and survivor organisations/groups
Partnership with parent and survivor organisations is essential to achieve the aims of promoting/ensuring optimal long-term care for survivors within the European countries. Childhood Cancer International – CCI (formerly ICCCPO, the International Confederation of Childhood Cancer Parents Organizations, www.icccpo.org) is part of or is a partner in EU-funded projects like PanCareSurFup, PanCareLIFE, ENCCA and ExPO-r-Net, where CCI members are cooperating with physicians on several levels, e.g.
Future work
Challenges for children and adolescents with cancer and the need for improvement of follow-up of survivors are described elsewhere [19], [20]. With the establishment of PanCare an interdisciplinary Network of experts in the field was created which continues to address challenges faced by long-term survivors of childhood cancer arising from successful treatment of their primary disease. The PanCare Network will together with international collaborators and groups continue to lead the way by
Financial support
The Seventh Framework Programme PanCareSurFup (Grant Agreement Number 257505), the Swedish Childhood Cancer Foundation, the Mikaela Hansen Foundation.
Conflict of interest statement
None declared.
Acknowledgements
We thank especially those survivors and families which support our Network by their presence at our meetings and their substantial input to our scientific research questions.
Current PanCare Board members are: E. Bárdi (Hungary), S. Essig (Switzerland), D. Grabow (Germany), M. Hawkins (UK), P. Kaatsch (Germany), S. Karner (Austria), T. Kepak (Czech Republic), G. Levitt (UK), G. Michel (Switzerland), M. Terenziani (Italy), R. Haupt (Italy), R. Skinner (UK) and as Honorary Secretary H. van der Pal
References (20)
- et al.
Long term survivors of childhood cancer: cure and care the Erice statement
Eur J Cancer
(2007) - et al.
Cancer in children and adolescents in Europe: developments over 20 years and future challenges
Eur J Cancer
(2006) - et al.
Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries
J Natl Cancer Inst
(2009) - et al.
Long-term survivors of childhood cancers in the United States
Cancer Epidemiol Biomark Prev
(2009) - et al.
Developing strategies for long term follow up of survivors of childhood cancer
BMJ
(2001) - et al.
The British Childhood Cancer Survivor Study: objectives, methods, population structure, response rates and initial descriptive information
Pediatr Blood Cancer
(2008) Cancer survivorship: unique opportunities for research
Cancer Epidemiol Biomark Prev
(2004)Long-term effects of childhood cancer need to be documented
J Natl Cancer Inst
(2003)- et al.
After-care of children and young adults surviving cancer. Initial recommendations by the late sequelae study group
Klin Padiatr
(1995) - et al.
Strategy for long-term surveillance at the German Childhood Cancer Registry – an update
Klin Padiatr
(2011)
Cited by (104)
Development and psychometric analysis of a pediatric cancer survivors Psychosocial Late Effects Scale (PCSLES)
2024, Journal of Pediatric NursingIncreased Cardiac Risk After a Second Malignant Neoplasm Among Childhood Cancer Survivors: A FCCSS Study
2023, JACC: CardioOncology